Readability & Display

Unofficial consolidated textConsolidated 2025-01-10English

Annex VIII

Reproduced from official EUR-Lex 10/1/2025.

Official catalogue · non-binding

Related guidance (10)

Current English catalogue entries that refer to Annex VIII. Guidance is non-binding and kept separate from the regulation text.

Browse topics
Manual on BorderlineManual on borderline and classification under Regulations (EU) 2017/745 and 2017/746 v5 Background note on the use of the Manual on borderline and classification for medical devices under the Directives.April 2026
Guidance documentCOVID-19 TESTS: Q&A on in vitro diagnostic medical device conformity assessment and performance in the context of COVID-19 (available in all EU languages and Arabic , Chinese , Japanese , Russian )February 2021
MDCG 2023-1Guidance on the health institution exemption under Article 5(5) of Regulation (EU) 2017/745 and Regulation (EU) 2017/746January 2023
MDCG 2020-16 rev.4Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746March 2025
MDCG 2021-22 rev.1Clarification on “first certification for that type of device” and corresponding procedures to be followed by notified bodies, in context of the consultation of the expert panel referred to in Article 48(6) of Regulation (EU) 2017/746September 2022
MDCG 2022-3 rev.1Verification of manufactured class D IVDs by notified bodiesDecember 2024
MDCG 2025-9Guidance on Breakthrough Devices (BtX) under Regulations 2017/745 & 2017/746Note: Pilot to roll-out the guidance is expected to be launched in Q2 2026December 2025
MDCG 2019-11 rev.1Qualification and classification of software - Regulation (EU) 2017/745 and Regulation (EU) 2017/746June 2025
Show all 10 guidance documentsShow only the first 8
MDCG 2021-18Applied-for scope of designation and notification of a conformity assessment body – Regulation (EU) 2017/746 (IVDR)July 2021
MDCG 2021-14Explanatory note on IVDR codesJuly 2021

Reader references